Cuba is using the humanized monoclonal antibody Itolizumab within the COVID-19 protocol for patients’ medical care to stop the so-called “cytokine storm,” an uncontrolled reaction of the immune system that can have fatal consequences. The drug, which is commonly used to treat other conditions such as psoriasis and rheumatoid arthritis, has been used in 70 … Continue reading Cuba uses monoclonal antibody to control “cytokine storm” in COVID-19 patients